Project Details
Projekt Print View

Shaping human nociceptor excitability via activation of sodium channel Nav1.9. Building a basis for innovative pain therapies.

Subject Area Experimental Models for the Understanding of Nervous System Diseases
Molecular Biology and Physiology of Neurons and Glial Cells
Term from 2017 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 386872283
 
Final Report Year 2023

Final Report Abstract

In this successful DFG project, we investigated the impact of voltage-gated sodium channels in regulating the excitability of neurons with specific focus on the subtype Nav1.9 and sensory neurons. To this end, we first investigated the biophysics of Nav gating in the context of disease. As the voltage-gated sodium channel Nav1.9 is thought to play a pivotal role in setting the resting membrane potential and fine-tuning action potentials, we aimed to investigate its biophysics and pharmacology/toxicology in detail. As this channel is historically hard to express, we used a chimera with Nav1.4, which renders measurable currents in heterologous expression systems. As translation from heterologous expression systems or rodents to human in pain research is limited, we optimized the differentiation of induced pluripotent stem cells (iPSCs) of healthy controls and patients suffering from pain or other diseases. We differentiated these iPSCs into neurons and assessed their excitability by patchclamp or multi-electrode-array to better understand the impact of genetic variation on neuronal excitability. In a proof-of-concept study, we were able to show the efficacy of lacosamide in ending the 10-year long suffering of a pain patient, by identifying treatment on patient-derived sensory neurons in the dish.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung